4-Hydroxyderricin and xanthoangelol from Ashitaba (Angelica keiskei) suppress differentiation of preadiopocytes to adipocytes via AMPK and MAPK pathways

Molecular Nutrition and Food Research

Volumn 57, Issue 10, 2013, Pages 1729-1740

  Zhang, Tianshun ^a   Sawada, Keisuke ^a   Yamamoto, Norio ^b   Ashida, Hitoshi ^a  

^a KOBE UNIVERSITY   (Japan)

^b HOUSE WELLNESS FOODS CORPORATION   (Japan)

Author keywords

AMP activated protein kinase; Ashitaba chalcones; CCAAT enhancer binding proteins; Mitogen activated protein kinases; Peroxisome proliferator activated receptor gamma

Indexed keywords

4 HYDROXYDERRICIN; 4-HYDROXYDERRICIN; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN BETA; CEBPA PROTEIN, MOUSE; CEBPB PROTEIN, MOUSE; CHALCONE; DRUG DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; XANTHOANGELOL;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; AMP-ACTIVATED PROTEIN KINASE; ANGELICA; ANIMAL; ARTICLE; ASHITABA CHALCONES; CCAAT/ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; GENETICS; LIPID METABOLISM; METABOLISM; MOUSE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASE; ASHITABA CHALCONES; CCAAT/ENHANCER-BINDING PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; AMP-ACTIVATED PROTEIN KINASES; ANGELICA; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHALCONE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPID METABOLISM; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLANT EXTRACTS; PPAR GAMMA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84884952635     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300020     Document Type: Article

References (40)

1. Friedman, J. M., Obesity in the new millennium. Nature 2000, 404, 632-634.
2. Kaul, K., Tarr, J. M., Ahmad, S. I., Kohner, E. M. et al., Introduction to diabetes mellitus. Adv. Exp. Med. Biol. 2012, 771, 1-11.
3. Vernooij, J. W., van der Graaf, Y., Visseren, F. L., Spiering, W., Smart study group, The prevalence of obesity-related hypertension and risk for new vascular events in patients with vascular diseases. Obesity (Silver Spring) 2012, 20, 2118-2123.
4. Vucenik, I., Stains, J. P., Obesity and cancer risk: evidence, mechanisms, and recommendations. Ann. N. Y. Acad. Sci. 2012, 1271, 37-43.
5. Ligibel, J., Obesity and breast cancer. Oncology (Williston Park) 2011, 25, 994-1000.
6. Goldstein, D. J., Beneficial health effects of modest weight loss. Int. J. Obes. Relat. Metab. Disord. 1992, 16, 397-415.
7. Green, H., Kehinde, O., An established preadipose cell line and its differentiation in culture II. Cell 1975, 5, 19-27.
8. Tontonoz, P., Hu, E., Spiegelman, B. M., Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994, 79, 1147-1156.
9. Lefterova, M. I., Lazar, M. A., New developments in adipogenesis. Trends Endocrinol. Metab. 2009, 20, 107-114.
10. Kaestner, K. H., Christy, R. J., Lane, M. D., Mouse insulin-responsive glucose transporter gene: characterization of the gene and trans-activation by the CCAAT/enhancer binding protein. Proc. Natl. Acad. Sci. USA 1990, 87, 251-255.
11. Ejaz, A., Wu, D., Kwan, P., Meydani, M., Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J. Nutr. 2009, 139, 919-925.
12. Gao, Y., Zhou, Y., Xu, A., Wu, D., Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cells. Biol. Pharm. Bull. 2008, 31, 1716-1722.
13. Sale, E. M., Atkinson, P. G., Sale, G. J., Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis. EMBO J. 1995, 14, 674-684.
14. Sakaue, H., Ogawa, W., Nakamura, T., Mori, T. et al., Role of MAPK phosphatase-1 (MKP-1) in adipocyte differentiation. J. Biol. Chem. 2004, 279, 39951-39957.
15. Camp, H. S., Tafuri, S. R., Leff, T., c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity. Endocrinology 1999, 140, 392-397.
16. Engelman, J. A., Lisanti, M. P., Scherer, P. E., Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis. J. Biol. Chem. 1998, 273, 32111-32120.
17. Rayalam, S., Della-Fera, M. A., Baile, C. A., Phytochemicals and regulation of the adipocyte life cycle. J. Nutr. Biochem. 2008, 19, 717-726.
18. Lu, C., Zhu, W., Shen, C. L., Gao, W., Green tea polyphenols reduce body weight in rats by modulating obesity-related genes. PLoS One 2012, 7, e38332.
19. Alappat, L., Awad, A. B., Curcumin and obesity: evidence and mechanisms. Nutr. Rev. 2010, 68, 729-738.
20. Gourineni, V., Shay, N. F., Chung, S., Sandhu, A. K. et al., Muscadine grape (Vitis rotundifolia) and wine phytochemicals prevented obesity-associated metabolic complications in C57BL/6J mice. J. Agric. Food Chem. 2012, 60, 7674-7681.
21. Kimura, Y., Taniguchi, M., Baba, K., Antitumor and antimetastatic activities of 4HD isolated from Angelica keiskei roots. Planta Med. 2004, 70, 211-219.
22. Akihisa, T., Motoi, T., Seki, A., Kikuchi, T. et al., Cytotoxic activities and anti-tumor-promoting effects of microbial transformation products of prenylated chalcones from Angelica keiskei. Chem. Biodivers. 2012, 9, 318-330.
23. Ohkura, N., Nakakuki, Y., Taniguchi, M., Kanai, S. et al., Xanthangelols isolated from Angelica keiskei inhibit inflammatory-induced plasminogen activator inhibitor 1 (PAI-1) production. Biofactors 2011, 37, 455-461.
24. Enoki, T., Ohnogi, H., Nagamine, K., Kudo, Y. et al., Antidiabetic activities of chalcones isolated from a Japanese herb, Angelica keiskei. J. Agric. Food Chem. 2007, 55, 6013-6017.
25. Kawabata, K., Sawada, K., Ikeda, K., Fukuda, I. et al., Prenylatedchalcones4-hydroxyderricin and xanthangelol stimulate glucose uptake in skeletal muscle cells by inducing GLUT4 translocation. Mol. Nutr. Food Res. 2011, 55, 467-475.
26. Huang, C., Zhang, Y., Gong, Z., Sheng, X. et al., Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARγ pathway. Biochem. Biophys. Res. Commun. 2006, 348, 571-578.
27. Ferguson, B. S., Nam, H., Hopkins, R. G., Morrison, R. F., Impact of reference gene selection for target gene normalization on experimental outcome using real-time qRT-PCR in adipocytes. Plos One 2010, 5, e15280.
28. T method. Methods 2001, 25, 402-408.
29. Furuyashiki, T., Nagayasu, H., Aoki, Y., Bessho, H. et al., Tea catechin suppresses adipocyte differentiation accompanied by down-regulation of PPARγ2 and C/EBPα in 3T3-L1 cells. Biosci. Biotechnol. Biochem. 2004, 68, 2353-2359.
30. Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A. et al., Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 1992, 358, 771-774.
31. Tontonoz, P., Graves, R. A., Vudavari, A. I., Erdjumentbromage, H. et al., Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR and RXR. Nucleic Acids Res. 1994, 22, 5628-5634.
32. Wu, Z., Rosen, E. D., Brun, R., Hauser, S. et al., Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 1999, 3, 151-158.
33. Cao, Z., Umek, R. M., McKnight, S. L., Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 1991, 5, 1538-1552.
34. Yeh, W. C., Cao, Z., Classon, M., McKnight, S. L., Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 1995, 9, 168-181.
35. Zhang, B. B., Zhou, G., Li, C., AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2009, 9, 407-416.
36. Luo, Z., Sha, A. K., Xiang, X., Ruderman, N. B., AMPK the metabolic syndrome and cancer. Trends Parmacol. Sci. 2005, 26, 69-76.
37. Bost, F., Aouadi, M., Caron, L., Binetruy, B., The role of MAPKs in adipocyte differentiation and obesity. Biochimie 2005, 87, 51-56.
38. Hu, E., Kim, J. B., Sarraf, P., Spiegelman, B. M., Inhibition of adipogenesis through MAPkinase-mediated phosphorylation of PPAR gamma. Science 1996, 274, 2100-2103.
39. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C. Z. et al., A central role for JNK in obesity and insulin resistance. Nature 2002, 420, 333-336.
40. Sabio, G., Cavanagh-Kyros, J., Ko, H. J., Jung, D. Y. et al., Prevention of steatosis by hepatic JNK1. Cell Metab. 2009, 10, 491-498.